Data and Technology

Offerings include treatment plans for a considerable number of illnesses and conditions, company says.

Study describes how a game theoretic model can successfully analyze how adoption of blockchain technology can reveal quality information.

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more.

The predicted value is largely driven by manufacturers' prioritization of brand protection.

Bloomlife’s MFM-Pro enables healthcare providers to measure maternal and fetal heart rate in the patient's home or clinic.

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.

Researchers from the University of Cambridge collaborated with Pfizer to develop a platform combining automated experiments with artificial intelligence to predict chemical reactions.

Cureus report discuss the value of AI, but the medical community must remain aware of privacy pitfalls.

The group—known as the Innovators' Network—is meant to serve as a link between entrepreneurs, providers, researchers, and payers while they strive to combat cardiovascular disease.

An overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.

Study investigates the gaps in access to this service, and how internet service impacts telehealth use.

Analysis reveals how QbTest is used to measure the effectiveness of ADHD drugs.

Electronic health record messaging network found to improve communication and lead to better medication adherence.

Provider’s Pithampur facility is recognized for its use of Industry 4.0 technology.

How pharma companies can be successful in financial forecasting, including why these forecasts should be powered by a patient-based approach.

Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.

This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance.

A panel designs a conceptual framework in an effort to limit partiality.

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

Creating a meaningful digital transformation requires pharmaceutical manufacturing companies to incorporate the right technologies, processes, and systems to reach their fullest potential.

Critical factors need to be addressed for pharma stakeholders to realize the full potential of generative artificial intelligence.

Digital twins allow the industry to integrate sustainable practices and supply chain efficiency solutions while ensuring patient safety.

Findings suggest that participants nationwide who were offered and accessed their online medical record has more than doubled in the past eight years, but racial and ethnic disparities continue.

Study estimates that up to 20% of the costs for clinical research is associated with the manual transfer and verification of data from the electronic medical record to a data capture system.

New initiative highlights importance of a collaborative approach that allows patients to share their insights and contribute value to studies.

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

A demand-driven methodology for data standardization across multiple streams of acquisition could improve the sharing of real-world data worldwide.

New E2E workflow orchestration service is expected to simplify the processes of health systems and retail pharmacies while also reducing the risk of recalled items reaching patients.

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.